Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations

Medicine, Oncology, Radiology +17

Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents

Manel Esteller, Jesús García‐Foncillas, Esther Andion et al. · New England Journal of Medicine · 2000 · 2.2K citations · Full text

Medicine, Molecular Biology, Oncology +17

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

Zvi Ram, Kenneth W. Culver, Eric M. Oshiro et al. · Nature Medicine · 1997 · 683 citations

Medicine, Cancer Biology, Oncology +16

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

Douglas W. Laske, Richard J. Youle, Edward H. Oldfield · Nature Medicine · 1997 · 530 citations

Medicine, Neuroscience, Oncology +10

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 334 citations · Full text

Medicine, Medicinal Chemistry, Nuclear Medicine +17